Silexion Therapeutics Corp. (SLXN)
NASDAQ · Healthcare
Silexion Therapeutics Corp. Revenue 2023–2025
Silexion Therapeutics Corp. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Silexion Therapeutics Corp. revenue for the quarter ending March 31, 2026 was 32000, a 1500.00% increase year-over-year.
- Silexion Therapeutics Corp. revenue for the twelve months ending March 31, 2026 was 117000.
- Silexion Therapeutics Corp. annual revenue for 2025 was 155000, a 453.57% increase from 2024.
- Silexion Therapeutics Corp. annual revenue for 2024 was 28000, a 81.70% decrease from 2023.
- Silexion Therapeutics Corp. annual revenue for 2023 was 153000.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Silexion Therapeutics Corp. Earnings — FAQ
Silexion Therapeutics Corp. (SLXN) earnings over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SLXN's earnings history?
The chart and table above show Silexion Therapeutics Corp.'s earnings by year and by quarter, including the growth rate.